Abstract:The idea of surgical treatment of type 2 diabetes was established in the U.S. and was based on observation of patients after bariatric operations. Performed in cases of morbid obesity exclusion of the duodenum and anastomose the stomach with the central part of the intestines cause shortened absorbtion of nutrients, what showed a beneficial effect on weight loss, resolution of comorbidities and reduce the risk of developing cardiovascular diseases and cancer. Analysis of the results of surgical treatment of obese patients with type 2 diabetes confirmed the usefulness of surgical methods.The aim of the study was to evaluate the impact of Roux-en-Y gastric by-pass (RYGB) on diabetes in patients with BMI below and above 35 kg/m2. Material and methods: The study comprised 66 patients with DM2, who underwent Roux-en-Y gastric bypass due to morbid obesity (BMI above 35 kg/m2) and three patients with DM2 and BMI below 35 kg/m2. In patients with DM2 and BMI < 35 kg/m2 criteria for inclusion in the operational treatment were: DM2 difficult to be regulated pharmacologically lasting less than 10 years and BMI at the qualification about 35 kg/m2. Indications have been determined on the basis of three consecutive measurements of HbA1c values above 7%, and measurements of blood glucose (frequent fluctuations in blood glucose levels on the value of hypoglycemia to hyperglycemia). Results: The criteria for diagnosing resolution of DM2 included the level of HbA1c < 6% and glucose fasting level below 100 mg/ dl. In a group of 66 patients with DM2 and obesity, regression of DM2 was observed in 48 patients (73%) as early as during the hospitalization. In 11 patients (16.7%) glycaemia and HBA1c were stabilized within 8 weeks after surgery. In 7 (10.6%) cases of patients with difficult to control DM2, there was still need for antidiabetic medication, but glycemic control was much more effective. After one year remission was observed in 89% of patients. In all three patients with DM2 and BMI < 35 kg/m2 total glycemic resolution of DM2 was observed during hospitalization. In this group there has been no postoperative complications. In the group of 66 obese patients with DM2 postoperative complications were found in 7 cases, they were related to infection and prolonged healing of surgical wound. One patient had an intraabdominal abscess located in the left subphrenic region, it was punctured under ultrasound guidance. Conclusions: The ultimate evaluation of this method demands several years of meticulous clinical studies. Despite of that, considering high cost of life-long conservative therapy of DM2 and its complications, severe impact on quality of life and serious consequences of the disease, the surgical metabolic intervention may become the most resonable solution in many cases.

Can Low BMI Chinese Patients with Type 2 Diabetes Benefit from Laparoscopic Roux-en-Y Gastric Bypass Surgery?

Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus Patients in Various Obesity Degree

Effectiveness and Safety of Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus

Roux-en-Y gastric bypass surgery for non obese type 2 diabetes patients

Effect of Roux-En-Y Gastric Bypass on the Remission of Type 2 Diabetes: A 3-Year Study in Chinese Patients with A Bmi < 30 Kg/M(2)

Roux-en-Y Gastric Bypass for T2D Treatment in Chinese Patients with Low BMI: 5-Year Outcomes

Analysis of long-term outcome of modified gastric bypass for type 2 diabetes mellitus in Chinese patients

Metabolic Effects and Safety of Roux‐en‐Y Gastric Bypass Surgery Vs. Conventional Medication in Obese Chinese Patients with Type 2 Diabetes

Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 Kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort

Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class

[Efficacy Evaluation of Laparoscopic Gastric Bypass for the Treatment of Obese Type 2 Diabetes Mellitus].

Long-limb Length Difference Had No Effect on Outcomes of Laparoscopic Roux-en-Y Gastric Bypass Surgery for Obese Chinese Patients with Type 2 Diabetes Mellitus: A CONSORT Compliant Article.

One stage laparoscopic therapy for gallbladder stones and type 2 diabetes of low body mass index

Efficacy of laparoscopic Roux-en-Y gastric bypass in the treatment of morbid obesity complicated with type 2 diabetes mellitus.

Efficacy of laparoscopic sleeve gastrectomy on morbidly obese patients with type 2 diabetes mellitus]

The Effect of Dyslipidemia on Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus

Visceral Fat Area As a New Predictor of Short-Term Diabetes Remission after Roux-en-Y Gastric Bypass Surgery in Chinese Patients with a Body Mass Index Less Than 35 Kg/m2

Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2

Comparative study on weight loss and remission of metabolic disorders after laparoscopic Roux-en-Y gastric by-pass versus laparoscopic sleeve gastrectomy

Comparison of Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy in Obese Patients with Type 2 Diabetes

Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m 2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study